Construction Tech Late Stage Investors & VC Firms
55 firms in this list, with a median first check of $1.4M. 22 of them lead rounds. Generated from verified public data and updated continuously.
PT1
BerlinPre-Seed–Late Stage$540K – $4.4M
5 people
Alder III Advisory
StockholmGrowth–Late Stage
14 people
Cheyenne Ventures
WoodsideSeries A–Late Stage
4 people
Aventurine Partners
HoustonGrowth–Late Stage
11 people
noa
LondonPre-Seed–Late Stage
11 people
Oval Park Capital
RaleighSeed–Late Stage$500K – $1.5M
2 people
Interlock Partners
DallasPre-Seed–Late Stage$1M – $5M
5 people
Prudence
New YorkSeed–Late Stage
5 people
Holden Capital
BrisbaneLate Stage$2M – $20M
6 people
Kilmer Group
TorontoGrowth–Late Stage$75M – $500M
ARM
LagosSeed–Late Stage
7 people
GI Corporation
HoustonGrowth–Late Stage
4 people
Yukon Capital Partners
TokyoGrowth–Late Stage
2 people
Odyssey Private Equity
Growth–Late Stage
4 people
Darahim Investment
Abu DhabiSeed–Late Stage
5 people
WAMEX Private Equity
Mexico CityGrowth–Late Stage
4 people
GreenSoil Building Innovation Fund
Ra'ananaSeed–Late Stage$500K
1 person
Munich Venture Partners
MunichPre-Seed–Late Stage
4 people
Cerity Partners Ventures
New YorkSeed–Late Stage
4 people
Legacy Capital Ventures
Seed–Late Stage
4 people
Pavonis
StaffordSeed–Late Stage
4 people
Cemex Ventures
MadridPre-Seed–Late Stage
DSK Capital
Late Stage
1Sharpe Capital
San FranciscoSeed–Late Stage
2 people
Related lists
Late Stage Investors & VC Firms (2726)Late Stage Investors & VC Firms in United States (1026)Healthtech Late Stage Investors & VC Firms (795)Late Stage Investors & VC Firms in Global (779)Enterprise Software Late Stage Investors & VC Firms (740)SaaS Late Stage Investors & VC Firms (735)Fintech Late Stage Investors & VC Firms (617)Late Stage Investors & VC Firms in Europe (599)Biotech Late Stage Investors & VC Firms (596)Consumer Late Stage Investors & VC Firms (586)
Data sourced from public filings and firms' own websites — see our methodology.













































